Medical Services International Awarded Contracts As a Result of Participation in Dubai Medical Conference
Posted on: Wednesday, 25 January 2006, 15:01 CST
EDMONTON, Alberta, Jan. 25 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has received orders for 1.5 million VScan HIV test kits as a result of its participation in the Dubai Medical Conference. These orders will generate revenue of approximately $3.5 million US over the next 15 months.
The orders totaling 1.5 million VScan HIV test kits are from two Middle East countries. Medical Services is to deliver the test kits in 12 equal orders over a period of one year starting May 1, 2006. Payment for the test kits will be by Irrevocable Letter of Credit from a Western Bank. In addition to the above, our distributor is negotiating with several other countries and expects to receive additional orders that will be in excess of 1.0 million HIV test kits. The company feels that this will be an excellent market for the VScan HIV test kit as a result of its accuracy and specialty use in remote areas using whole blood so that the testing can be completed without medical facilities and trained medical personnel. There has also been significant interest in our VScan TB test kits and Hepatitis C test kits. We believe that these test kits will generate a secondary market.
About VScan
The VScan rapid test kit is a single use, easy to use test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Malaria, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to, new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
First Call Analyst: FCMN Contact:
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or media contact BillWhitehead, +1-416-822-5883, both of Medical Services International Inc.
Web site: http://www.medicalservicesintl.com/http://www.minerva-biotech.com/
Source: PRNewswire-FirstCall
Related Articles
- CSC Announces Agreement to Provide Billing Service to Littleton Internal Medicine Associates
- Nutra Pharma Announces Designer Diagnostics Test Kit Technology to Be Presented at International Lung Health Conference
- Latest Clinical Data on the Corgenix AspirinWorks(R) Test Kit to Be Presented at the International Society on Thrombosis and Hemostasis (ISTH) Meeting From July 6-12, 2007
- Medical Services Completes Further Testing of Its VScan HIV Test Kit With Excellent Results
- Medical Services International Begins Shipping VScan TB Test Kits to South Africa
- Medical Services International to Begin Shipping VScan HIV Test Kits Into Europe
- Medical Services VScan HIV Test Kit Used During LIVE Test on Television
- Medical Services International to Supply VScan Test Kits for Private Testing
- Medical Services Receives Order for 1.0 Million VScan Test Kits From the Middle East
- Medical Services Receives Regulatory Approval for Its VScan Tuberculosis (TB) Rapid Test Kit
 |
 |
User Comments (0)
RSS Feeds